Pushkal Garg, CMO & EVP Development & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 14,749 shares at $183.58 ($2.7M) on 2023-08-07, disclosed to the SEC on 2023-08-07.
Open-market sale of $2.7M ALNY by CMO & EVP Development & Med Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $184.70 | 658 | $122K | 4.5% |
| 2 | $184.70 | 658 | $122K | 4.5% |
| 3 | $185.54 | 1,593 | $296K | 10.8% |
| 4 | $185.54 | 1,593 | $296K | 10.8% |
| 5 | $186.39 | 945 | $176K | 6.5% |
| 6 | $186.39 | 945 |
| $176K |
| 6.5% |
| 7 | $187.37 | 86 | $16K | 0.6% |
| 8 | $188.40 | 15 | $3K | 0.1% |
| 9 | $189.31 | 164 | $31K | 1.1% |
| 10 | $183.58 | 3,112 | $571K | 21.0% |
| 11 | $183.58 | 3,112 | $571K | 21.0% |
| 12 | $184.65 | 814 | $150K | 5.5% |
| 13 | $184.65 | 814 | $150K | 5.5% |
| 14 | $185.32 | 240 | $44K | 1.6% |
| Total | $184.70 avg | 14,749 | $2.7M | 100% |
| Filing → |
| ALNY | SELL | 2026-03-02 | $1.5M | — | Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |